New law consolidating over 40 years of UK drugs legislation enters into force
This article was originally published in SRA
Executive Summary
The Human Medicines Regulations 2012 has entered into force in the UK, consolidating and simplifying over 40 years of the country's drugs legislation in such a way as to reduce regulatory burden on businesses1,2.
You may also be interested in...
Five Years On: UK Reviews Transposition Of EU Pharmacovigilance Directive, Other Changes
The UK medicines regulator is undertaking a post-implementation review of the Human Medicines Regulations 2012, which introduced significant changes for the medicines sector such as national requirements in relation to the EU pharmacovigilance directive.
EMA Probe Finds No Link Between GLP-1s And Suicidal Thoughts & Actions
After reviewing the evidence from non-clinical studies, clinical trials, post-marketing surveillance data and other studies, the European Medicines Agency said there was no need to update the product information for 11 diabetes and weight management drugs.
English Funding For Aquipta Targets AbbVie’s Migraine Drug To 170,000 People
Aquipta is the first oral treatment that NICE has recommended for preventing chronic migraines in the fourth-line setting, and the second oral treatment for episodic migraines in the same setting. The drug has already secured reimbursement in Scotland, Sweden and Israel.